Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing

Leila Ahmed North America Legal Chronicle
Tagged:

Gibson Dunn has advised Korsana Biosciences. Ropes & Gray has advised Cyclerion Therapeutics. Korsana Biosciences and Cyclerion Therapeutics, Inc. have entered into a definitive agreement to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here